Publications by authors named "Mike R Russell"

Claim this Profile
T
The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Mario Capasso, Lee D McDaniel, Flora Cimmino, Andrea Cirino, Daniela Formicola, Mike R Russell

J Cell Mol Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.
Lori S Hart, JulieAnn Rader, Pichai Raman, Vandana Batra, Mike R Russell

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.
Mike R Russell, Annalise Penikis, Derek A Oldridge, Juan R Alvarez-Dominguez, Lee McDaniel

Cancer Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare variants in TP53 and susceptibility to neuroblastoma.
Sharon J Diskin, Mario Capasso, Maura Diamond, Derek A Oldridge, Karina Conkrite, Mike R Russell

J Natl Cancer Inst· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.
Julieann Rader, Mike R Russell, Lori S Hart, Michael S Nakazawa, Lili T Belcastro

Clin Cancer Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1β promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features.
Qingxin Liu, Mike R Russell, Kristina Shahriari, Danielle L Jernigan, Mercedes I Lioni

Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma.
Mike R Russell, Kirill Levin, JulieAnn Rader, Lili Belcastro, Yimei Li

Cancer Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma.
Kristina A Cole, Jonathan Huggins, Michael Laquaglia, Chase E Hulderman, Mike R Russell

Proc Natl Acad Sci U S A· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the {alpha} receptor for platelet-derived growth factor as a primary or combination therapy in a preclinical model of prostate cancer skeletal metastasis.
Mike R Russell, Qingxin Liu, Alessandro Fatatis

Clin Cancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms.
Mike R Russell, Qingxin Liu, Hetian Lei, Andrius Kazlauskas, Alessandro Fatatis

Cancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.
Nathan G Dolloff, Mike R Russell, Nick Loizos, Alessandro Fatatis

Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis